Implementation of a process-scale adenovirus purification with a single-use platform by Boulais, Amélie et al.
IMPLEMENTATION OF A PROCESS-SCALE ADENOVIRUS PURIFICATION WITH A SINGLE-USE 
PLATFORM 
 
Amélie Boulais, Sartorius Stedim Biotech 
amelie.boulais@sartorius-stedim.com 
Maria Mellado, Sartorius Stedim Biotech 
Miyako Hirai, Sartorius Stedim Biotech 
Cristina Peixoto, IBET 
 
 
Key words: adenovirus purification, single-use platform, clarification, UF/DF, membrane chromatography 
 
Adenovirus vectors are finding increasing application within the vaccine and gene therapy industries. 
Companies developing adenovirus-based biopharmaceuticals will benefit from single-use process platforms that 
are quick and easy to install and have been demonstrated previously to produce purified adenovirus. The 
platform can be adapted to new adenovirus products with a minimum investment of time and resource in 
process development activities. We have assembled a platform from existing and proven technologies, available 
from lab to production scale, that meet the quality requirements of the vaccine industry. The platforms includes 
clarification, ultrafiltration/diafiltration, chromatography and sterile filtration steps. The approach has been 
successfully demonstrated for the purification of an Adenovirus serotype 5 vector, at the 20 L scale. It allows the 
complete purification of the vaccine in one day.  
 
 
